Mouth Abnormalities: Clinical Trials

14 trials for Mouth Abnormalities, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 2 recruiting, 1 enrolling by invitation, 1 not yet recruiting. 14 Phase 2, 4 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 214Completed 9, Recruiting 2, Enrolling by invitation 1, Not yet recruiting 1, Withdrawn 1
Phase 14Completed 3, Recruiting 1
Phase 31Completed 1

Follow Mouth Abnormalities: new trials by email Literature Review of Mouth Abnormalities trials Research Report on Mouth Abnormalities

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cleft Lip Scarring After Botox
Botulinum Toxin Type A (BOTOX) Injection, Normal Saline - Cleft Lip, Cleft Lip Scar
Phase 2RecruitingChildren's National Research Institute402026-02-192026-10-19
Efficacy and Safety of Allogenic Cultured Adipose-derived Mesenchymal Stromal Cell Injections on MoUth Fibrosis and Handicap in Patients With Systemic sclEroderma
AdMSC, Placebo - Systemic Scleroderma
Phase 2Not yet recruitingUniversity Hospital, Toulouse502026-01-012026-01-08
Evaluation of a Novel Nasal Conformer in Pediatric Patients
use of an anatomically designed nasal conformer - Cleft Lip, Nasal Surgical Procedures
Phase 2Enrolling by invitationEast Tennessee Children's Hospital202025-06-012026-09-16
Phase I-IIa, to Evaluate the Safety, Feasibility, and Efficacy of the Use of BIOCLEFT in the Treatment of Cleft Palate.
implantation with an autologous human palatal mucosa substitute made of nanostructured fibrin-agarose generated by tissue engineering (BIOCLEFT). - Cleft Lip and Palate
Phase 1 / Phase 2RecruitingElisa María Cubiles Montero de Espinosa152024-04-172024-05-10
Suprazygomatic Block in Cleft Palate Surgery in Children
Bupivacaine, Dexmedetomidine, paracetamol - Cleft Palate
Phase 2CompletedAssiut University802018-01-142018-09-24
Comparative Study Between Levobupivacaine and Bupivacaine for Nerve Block During Pediatric Primary Cleft Palate Surgery
Levobupivacaine, Bupivacaine - Recovery After Cleft Palate Surgery
Phase 2 / Phase 3CompletedAssiut University602016-01-012017-09-07
IV Acetaminophen in Children Undergoing Palatoplasty
IV acetaminophen, Placebo - Cleft Palate
Phase 2WithdrawnNationwide Children's Hospital2015-12-012016-03-08
Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair
Botulinum Toxin Type A, Normal Saline Injection - Cleft Lip, Scarring
Phase 1 / Phase 2CompletedThe University of Texas Health Science Center, Houston302015-12-012021-11-03
Description of Pain in Pediatric Patients With Cleft Lip and Palate Undergoing Alveolar Grafting Using Two Surgical Strategies: Stem Cells and Autogenous Iliac Crest Bone (Pain Evaluation in Children Undergoing Alveolar Grafting: Stem Cells vs. Iliac Crest Bone)
Autogenous Iliac Crest Bone Grafting, Bioengineered Alveolar Grafting (SHED + Scaffold) - Clift Lip, Cleft Palate
Phase 1 / Phase 2CompletedHospital Sirio-Libanes202015-03-012026-07-29
Cell Therapy for Craniofacial Bone Defects
Ixmyelocel-T, Autogenous Bone Grafting - Cleft Palate, Trauma
Phase 1 / Phase 2CompletedUniversity of Michigan182012-08-012017-05-04
Does Use of Rigid Fixation After Removing Distraction Osteogenesis Device Reduce the Relapse?
mini plate - Cleft Palate, Maxillary Hypoplasia
Phase 2CompletedShiraz University of Medical Sciences202011-02-012015-01-30
Preventing Complications in Cleft Palate Repair With Antibiotics
Unasyn, saline solution - Cleft Palates
Phase 2CompletedJoseph Losee2242008-05-012018-02-01
Cleft Orthognathic Surgery Versus Distraction Osteogenesis - Which is Better?
Orthognathic surgery, Distraction osteogenesis - Cleft Lip and Palate, Maxillary Hypoplasia
Phase 2CompletedThe University of Hong Kong602002-06-012011-09-13
Cleft Palate Surgery and Speech Development
Furlow double z-plasty palatoplasty palate repair, Von Langenbeck palatoplasty palate repair - Cleft Lip, Cleft Palate
Phase 2CompletedUniversity of Florida4751996-02-012011-09-20

Narrower conditions

Cleft Palate (9)  ·  Cleft Lip (7)  ·  Retrognathia (2)  ·  Alveolar Bone Loss (1)  ·  Cicatrix (1)  ·  Microstomia (1)  ·  Pain, Postoperative (1)  ·  Scleroderma, Systemic (1)  ·  Speech (1)  ·  Wounds and Injuries (1)

Broader conditions

Congenital Abnormalities (14)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (14)  ·  Mouth Diseases (14)  ·  Stomatognathic Diseases (14)  ·  Stomatognathic System Abnormalities (14)  ·  Craniofacial Abnormalities (10)  ·  Jaw Abnormalities (10)  ·  Jaw Diseases (10)  ·  Maxillofacial Abnormalities (10)  ·  Musculoskeletal Abnormalities (10)  ·  Musculoskeletal Diseases (10)  ·  Lip Diseases (7)  ·  Mandibular Diseases (2)  ·  Pathologic Processes (2)

Interventions

Saline Solution (3)  ·  Acetaminophen (2)  ·  Botulinum Toxins, Type A (2)  ·  Bupivacaine (2)  ·  Ampicillin (1)  ·  Dexmedetomidine (1)  ·  Drug Implants (1)  ·  Levobupivacaine (1)  ·  Orthognathic Surgery (1)  ·  Osteogenesis, Distraction (1)  ·  Sodium Chloride (1)  ·  Sulbactam (1)  ·  sultamicillin (1)

Sponsors

Assiut University (2)  ·  Children's National Research Institute (1)  ·  East Tennessee Children's Hospital (1)  ·  Elisa María Cubiles Montero de Espinosa (1)  ·  Hospital Sirio-Libanes (1)  ·  Joseph Losee (1)  ·  Nationwide Children's Hospital (1)  ·  Shiraz University of Medical Sciences (1)  ·  The University of Hong Kong (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  University Hospital, Toulouse (1)  ·  University of Florida (1)  ·  University of Michigan (1)

Countries

United States (7)  ·  Brazil (2)  ·  Egypt (2)  ·  France (1)  ·  Hong Kong (1)  ·  Iran (1)  ·  Spain (1)

Top investigators

Darnell Kaigler, DDS, PhD (1)  ·  Jaecel O Shah, MD (1)  ·  Joseph Losee, MD (1)  ·  Lim K Cheung, BDS, PhD (1)  ·  Negin Matini, DMD (1)  ·  Reza Tabrizi, DMD (1)  ·  Touba Karagah, DMD (1)  ·  William N Williams, Ph.D (1)

Results publications

PMID 39638596

NIH funding

R01DE010437 (1)